Taysha Gene Therapies, Inc. (TSHA)
5.49
-0.05
(-0.90%)
USD |
NASDAQ |
May 22, 16:00
5.49
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies Shareholders Equity (Quarterly) : 211.94M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | -553.84M |
| United Therapeutics Corp. | 5.901B |
| TG Therapeutics, Inc. | 583.13M |
| ADMA Biologics, Inc. | 390.32M |
| UroGen Pharma Ltd. | -124.25M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 300.35M |
| Total Liabilities (Quarterly) | 88.41M |
| Debt to Equity Ratio | 0.3247 |
| Current Ratio | 14.03 |
| Net Debt Paydown Yield | -0.08% |